Pluri Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Yaacov Yanay, with a market cap of $35.3M.
Common questions about Pluri Inc.
Pluri Inc. is scheduled to report earnings for Q3 2026 on May 12, 2026 after market close. Analysts estimate revenue of $655.0K.
Pluri Inc. has approximately 134 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.